How GLP-1 Weight-Loss Drugs Are Reshaping Food and Drink

Weight-loss medicines are changing the food and beverage market, boosting demand for nutrient-rich, portion-controlled products and creating fresh opportunities for innovation across the sector

GLP-1 innovation overview

• GLP-1 drugs are driving significant food and beverage innovation
• Manufacturers are reformulating products with more protein and fibre
• Portion-controlled formats are gaining traction among health-conscious consumers
• Price remains crucial despite growing demand for healthier products
• GLP-1 trends could reshape mainstream food development long term

GLP-1 drugs are no longer a niche topic for the food and beverage industry.

Ingredient suppliers are pushing innovation, brands are speeding up development, and retailers are looking for new ways to reach shoppers who are increasingly focused on health.

Although debate continues over how appetite-suppressing medicines will affect overall food and drink consumption, industry observers say they are also unlocking a wide range of new product-development opportunities.

The GLP-1 effect

“There’s a growing trend for smaller packs, or smaller portions in resealable packaging, of nutrient dense foods with high protein, fibre and functional claims and re-formulated products with low fat, salt, sugar and calories,” says Ananda Roy, senior vice president of industry analysts at Circana. “These are the clearest signs yet that GLP-1 and weight-management trends are changing the industry.”

One of the strongest signs of that shift came from the world’s largest consumer packaged goods company.

Nestlé said it is developing a new generation of nutrition products for consumers using GLP-1 weight-loss medications, using artificial intelligence and nutritional science to identify ingredient combinations that support muscle health, hydration and nutritional intake. The company is also examining reformulation possibilities across its existing range and creating products intended to address some of the nutritional issues linked to eating less.

The move shows how quickly the discussion around GLP-1s has changed. What first looked like a potential threat to food and beverage sales is now increasingly seen as an opportunity, with manufacturers focused on delivering more nutrition in smaller servings.

As Nestlé chief technology officer Stefan Palzer put it: “It’s a huge opportunity for our company.”

Even so, some categories are more exposed to changing consumer behaviour than others.

“Traditional beer, wine and spirit categories are showing clear signs of disruption with volumes down, despite high levels of promotion,” says Circana’s Roy. “In comparison, categories that provide high nutrient density, or make functional health and wellness claims, even if consumed as an indulgence or are an occasional food like snacks, are most likely benefit from the consumer’s desire for healthier dietary choices.”

For confectionery makers, the shift brings both pressure and potential. Reduced appetite may curb impulse buys and big-format consumption, but it is also increasing demand for smaller packs, protein-enhanced snacks and treats that combine indulgence with functional benefits. Many companies are now trying to offer more nutrition without losing taste or enjoyment.

The industry response has been quick.

Reformulation and new product development accelerate

Across the market, companies are taking a two-track approach: improving existing products through reformulation and launching new products that match changing consumer needs.

“Brands are doing both,” Roy says. “In some established snack and beverage categories, we’re seeing reformulation of existing products with lower sugar, fat and calorie content, coupled with added protein and fibre. Similarly, confectionery and baking products are being formulated with more protein and fibre.”

At the same time, there has been strong growth in products created specifically for people using weight-management medicines. High-protein snacks, meal replacements, fibre-enriched foods and portion-conscious formats are increasingly aimed at consumers looking for satiety, nutrition and convenience in smaller servings.

That trend reflects a wider shift in product development. Rather than treating GLP-1 users as a small niche, many manufacturers now see them as an early signal of broader demand for foods and drinks with greater nutritional value.

As a result, the changes unfolding now could reach far beyond current users of these medicines, shaping formulation, packaging and innovation plans across the wider industry.

Nutrition professor Marion Nestle says companies are already moving rapidly to respond.

“They’re already making products high in protein, vitamins, and fibre, and low in sugar and calories.”

She also believes GLP-1 use will reinforce broader health-focused innovation trends. In her view, it is “already happening”.

Even as development accelerates, price remains one of the most important factors in buying decisions.

The GLP-1 price challenge

According to Circana’s Roy, affordability is one of the clearest signs of changing market conditions.

“Average price premiums for new food and beverage products have dropped,” he says. “Previously, a newly launched food or drink product could typically cost about 15% more than an existing alternative. Now, that premium is only around 6%.”

In other words, consumers still want innovation, but they are less willing to pay a large premium for it.

Roy says that reflects the growing pressure of inflation on household budgets.

That means the next wave of products will need to deliver health benefits and value at the same time. Meeting that expectation will be central to the next stage of GLP-1-led innovation.

The future of GLP-1 innovation

If the first phase of GLP-1 innovation has focused on reformulation, portion control and added protein, the next phase is likely to centre on more personalised nutrition, functional ingredients and products designed to support long-term health and wellbeing.

As consumers place more importance on satiety, nutrient density and overall wellness, manufacturers are under pressure to deliver more nutrition in every bite and sip.

That is expected to drive further investment in high-protein formulations, fibre fortification, functional ingredients and products designed to support hydration, muscle maintenance and metabolic health.

Packaging is also likely to keep evolving, with more emphasis on portion guidance, resealability and convenience.

The effects may stretch well beyond people currently taking weight-management medicines. Many of the features associated with GLP-1-focused products, including higher protein, lower sugar, improved nutrition and controlled portions, already fit with broader health and wellness trends that have been building for years.

As a result, the innovations emerging now may help steer mainstream food and beverage development, whether or not GLP-1 adoption keeps growing.

The challenge is to balance nutrition, taste, convenience and affordability. Brands that can deliver all four are likely to benefit from a market that is increasingly prioritising quality over quantity. As GLP-1 use continues to shape consumer expectations, the products being created now could help define the future of food and drink.

Weight Management Broadcast

Discover more about the opportunities for food and beverage within the weight management space, with our dedicated Weight Management broadcast.